^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CRTE7A2-01

    i
    Associations
    News

    Trials

    Company:
    CorreGene
    Drug class:
    HPV-16 E6 protein inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers (NCT05122221)
    Phase 1
    Corregene Biotechnology Co., Ltd
    Recruiting
    Last update posted :
    06/28/2022
    Initiation :
    07/17/2022
    Primary completion :
    03/01/2023
    Completion :
    12/01/2024
    HLA-A
    |
    HLA-A*02
    |
    cyclophosphamide • fludarabine IV • CRTE7A2-01 • cyclophosphamide intravenous